These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 15632910)

  • 1. Inhibition of growth and telomerase activity by novel cationic ceramide analogs with high solubility in human head and neck squamous cell carcinoma cells.
    Rossi MJ; Sundararaj K; Koybasi S; Phillips MS; Szulc ZM; Bielawska A; Day TA; Obeid LM; Hannun YA; Ogretmen B
    Otolaryngol Head Neck Surg; 2005 Jan; 132(1):55-62. PubMed ID: 15632910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent antitumor activity of a novel cationic pyridinium-ceramide alone or in combination with gemcitabine against human head and neck squamous cell carcinomas in vitro and in vivo.
    Senkal CE; Ponnusamy S; Rossi MJ; Sundararaj K; Szulc Z; Bielawski J; Bielawska A; Meyer M; Cobanoglu B; Koybasi S; Sinha D; Day TA; Obeid LM; Hannun YA; Ogretmen B
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1188-99. PubMed ID: 16510697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of head and neck squamous cell carcinoma growth and invasion by the calcium influx inhibitor carboxyamido-triazole.
    Wu Y; Palad AJ; Wasilenko WJ; Blackmore PF; Pincus WA; Schechter GL; Spoonster JR; Kohn EC; Somers KD
    Clin Cancer Res; 1997 Nov; 3(11):1915-21. PubMed ID: 9815580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Head and neck squamous cell carcinoma is highly sensitive to vinorelbine in Vitro.
    Erjala K; Pulkkinen J; Kulmala J; Alanen K; Grenman R
    Anticancer Res; 2002; 22(6A):3135-42. PubMed ID: 12530056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin resistance of the HNSCC cell line UT-SCC-26A can be overcome by stimulation of the EGF-receptor.
    Mandic R; Rodgarkia-Dara CJ; Krohn V; Wiegand S; Grénman R; Werner JA
    Anticancer Res; 2009 Apr; 29(4):1181-7. PubMed ID: 19414362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prestimulation of head and neck cancer cells with growth factors enhances treatment efficacy.
    Hambek M; Werner C; Baghi M; Gstöttner W; Knecht R
    Anticancer Res; 2006; 26(2A):1091-5. PubMed ID: 16619511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic effects of the oncolytic herpes simplex virus HSV1716 alone and in combination with cisplatin in head and neck squamous cell carcinoma.
    Mace AT; Harrow SJ; Ganly I; Brown SM
    Acta Otolaryngol; 2007 Aug; 127(8):880-7. PubMed ID: 17763002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment with 5-FU enhances cisplatin cytotoxicity in head and neck squamous cell carcinoma cells.
    Ijichi K; Adachi M; Hasegawa Y; Ogawa T; Nakamura H; Kudoh A; Yasui Y; Murakami S; Ishizaki K
    Cancer Chemother Pharmacol; 2008 Oct; 62(5):745-52. PubMed ID: 18075740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p38alpha and p38delta mitogen-activated protein kinase isoforms regulate invasion and growth of head and neck squamous carcinoma cells.
    Junttila MR; Ala-Aho R; Jokilehto T; Peltonen J; Kallajoki M; Grenman R; Jaakkola P; Westermarck J; Kähäri VM
    Oncogene; 2007 Aug; 26(36):5267-79. PubMed ID: 17334397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of short-chain fatty acids on head and neck squamous carcinoma cells.
    Krishna S; Brown N; Faller DV; Spanjaard RA
    Laryngoscope; 2002 Apr; 112(4):645-50. PubMed ID: 12150517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STI-571 (Gleevec) potentiates the effect of cisplatin in inhibiting the proliferation of head and neck squamous cell carcinoma in vitro.
    Wang-Rodriguez J; Lopez JP; Altuna X; Chu TS; Weisman RA; Ongkeko WM
    Laryngoscope; 2006 Aug; 116(8):1409-16. PubMed ID: 16885745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of telomerase inhibitors on oral squamous carcinoma cells].
    Yang Z; Chen W; Zhang Q
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Jun; 21(3):231-4. PubMed ID: 12898773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo activity of protein kinase C inhibitor chelerythrine chloride induces tumor cell toxicity and growth delay in vivo.
    Chmura SJ; Dolan ME; Cha A; Mauceri HJ; Kufe DW; Weichselbaum RR
    Clin Cancer Res; 2000 Feb; 6(2):737-42. PubMed ID: 10690561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues.
    Mao L; El-Naggar AK; Fan YH; Lee JS; Lippman SM; Kayser S; Lotan R; Hong WK
    Cancer Res; 1996 Dec; 56(24):5600-4. PubMed ID: 8971162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent activity of a novel dimeric heat shock protein 90 inhibitor against head and neck squamous cell carcinoma in vitro and in vivo.
    Yin X; Zhang H; Burrows F; Zhang L; Shores CG
    Clin Cancer Res; 2005 May; 11(10):3889-96. PubMed ID: 15897590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence-dependent antitumor effects of differentiation agents in combination with cell cycle-dependent cytotoxic drugs.
    Verheul HM; Qian DZ; Carducci MA; Pili R
    Cancer Chemother Pharmacol; 2007 Aug; 60(3):329-39. PubMed ID: 17256134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase as an independent prognostic factor in head and neck squamous cell carcinoma.
    Liao CT; Tung-Chieh Chang J; Wang HM; Chen IH; Lin CY; Chen TM; Hsieh LL; Cheng AJ
    Head Neck; 2004 Jun; 26(6):504-12. PubMed ID: 15162351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amplification of cancer cell apoptosis in photodynamic therapy-treated tumors by adjuvant ceramide analog LCL29.
    Korbelik M; Zhang W; Separovic D
    Lasers Surg Med; 2011 Sep; 43(7):614-20. PubMed ID: 22057489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical usefulness of telomerase activation and telomere length in head and neck cancer.
    Patel MM; Parekh LJ; Jha FP; Sainger RN; Patel JB; Patel DD; Shah PM; Patel PS
    Head Neck; 2002 Dec; 24(12):1060-7. PubMed ID: 12454944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amplification of wild-type K-ras promotes growth of head and neck squamous cell carcinoma.
    Hoa M; Davis SL; Ames SJ; Spanjaard RA
    Cancer Res; 2002 Dec; 62(24):7154-6. PubMed ID: 12499248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.